Matches in SemOpenAlex for { <https://semopenalex.org/work/W3094372592> ?p ?o ?g. }
Showing items 1 to 79 of
79
with 100 items per page.
- W3094372592 endingPage "S839" @default.
- W3094372592 startingPage "S839" @default.
- W3094372592 abstract "INTRODUCTION: Clostridium difficile (C. diff) infection has increasing incidence in 21st century, particularly in elderly patients. In a patient on coumadin, we report an unexpected decrease in International Normalized Ratio (INR) during the treatment of second recurrence of C. Diff treated with fidaxomicin. According to the available information, fidaxomicin doesn’t interfere with warfarin, but in this case warfarin effects diminished and only with increased dosage therapeutic INR was achieved. CASE DESCRIPTION/METHODS: 66-year-old Female with Past Medical History of Hypertension, Diabetes, C.diff infection a year ago, Right Internal Jugular Vein Thrombus on Coumadin presented with diffuse abdominal pain and diarrhea. Diarrhea worsening in the few days before admission with frequency of 5-7 times per day, liquid in consistency. C.diff testing came back positive. White blood cell count stayed around 5000/Microliter during the admission, so we classified it as a nonsevere episode of C.diff. Patient was started on the Fidaxomicin therapy as this was her 1st recurrence and initial episode was treated with Vancomycin. From the next day of starting Fidaxomicin INR started declining (#Figure 1), it became subtherapeutic requiring more coumadin dose reaching to 10mg per day from baseline 3mg per day. Apart from Fidaxomicin and Coumadin, patient was on Metoprolol, Nifedipine, Insulin during the hospital stay, none of the above has proven to cause the subtherapeutic INR. Patient remained on the same low salt diet during the hospital stay. Patient remained in the hospital for 2 weeks for severe diarrhea, subtherapeutic INR and eventually supratherapeutic INR. DISCUSSION: Incidence of the C. diff infection is increasing and so is the use of the drugs to treat it. Guidelines recommend fidaxomicin as a treatment option for the severe or non-severe initial episode of C. Diff infection, first recurrence (if vancomycin given for the initial episode), and second or subsequent recurrence. From our case, we recommend a careful use of Fidaxomicin in C. diff when patient is on Coumadin and at high risk for clots. Alternate regimen such as the prolonged pulse taper of Vancomycin should be used for the C.diff recurrences. There is only one article about this interaction in the literature and as Gastroenterologists increase the use of this drug to treat C.Diff infection, further studies need to be done to confirm this interaction to prevent catastrophic complications in the elderly with subtherapeutic INR.Figure 1.: Line Graph showing the Effect of Fidaxomicin on the INR." @default.
- W3094372592 created "2020-10-29" @default.
- W3094372592 creator A5027272545 @default.
- W3094372592 creator A5044510694 @default.
- W3094372592 creator A5077767376 @default.
- W3094372592 date "2020-10-01" @default.
- W3094372592 modified "2023-09-24" @default.
- W3094372592 title "S1635 Fidaxomicin Use for Clostridium difficile Infection Decreases the Effect of Coumadin in Elderly" @default.
- W3094372592 doi "https://doi.org/10.14309/01.ajg.0000708588.53812.3a" @default.
- W3094372592 hasPublicationYear "2020" @default.
- W3094372592 type Work @default.
- W3094372592 sameAs 3094372592 @default.
- W3094372592 citedByCount "1" @default.
- W3094372592 countsByYear W30943725922021 @default.
- W3094372592 crossrefType "journal-article" @default.
- W3094372592 hasAuthorship W3094372592A5027272545 @default.
- W3094372592 hasAuthorship W3094372592A5044510694 @default.
- W3094372592 hasAuthorship W3094372592A5077767376 @default.
- W3094372592 hasBestOaLocation W30943725921 @default.
- W3094372592 hasConcept C120665830 @default.
- W3094372592 hasConcept C121332964 @default.
- W3094372592 hasConcept C126322002 @default.
- W3094372592 hasConcept C141071460 @default.
- W3094372592 hasConcept C2776301958 @default.
- W3094372592 hasConcept C2778300832 @default.
- W3094372592 hasConcept C2778980435 @default.
- W3094372592 hasConcept C2779161974 @default.
- W3094372592 hasConcept C2779489039 @default.
- W3094372592 hasConcept C2779802037 @default.
- W3094372592 hasConcept C2781342628 @default.
- W3094372592 hasConcept C2994496256 @default.
- W3094372592 hasConcept C501593827 @default.
- W3094372592 hasConcept C523546767 @default.
- W3094372592 hasConcept C54355233 @default.
- W3094372592 hasConcept C61511704 @default.
- W3094372592 hasConcept C71924100 @default.
- W3094372592 hasConcept C86803240 @default.
- W3094372592 hasConcept C89423630 @default.
- W3094372592 hasConceptScore W3094372592C120665830 @default.
- W3094372592 hasConceptScore W3094372592C121332964 @default.
- W3094372592 hasConceptScore W3094372592C126322002 @default.
- W3094372592 hasConceptScore W3094372592C141071460 @default.
- W3094372592 hasConceptScore W3094372592C2776301958 @default.
- W3094372592 hasConceptScore W3094372592C2778300832 @default.
- W3094372592 hasConceptScore W3094372592C2778980435 @default.
- W3094372592 hasConceptScore W3094372592C2779161974 @default.
- W3094372592 hasConceptScore W3094372592C2779489039 @default.
- W3094372592 hasConceptScore W3094372592C2779802037 @default.
- W3094372592 hasConceptScore W3094372592C2781342628 @default.
- W3094372592 hasConceptScore W3094372592C2994496256 @default.
- W3094372592 hasConceptScore W3094372592C501593827 @default.
- W3094372592 hasConceptScore W3094372592C523546767 @default.
- W3094372592 hasConceptScore W3094372592C54355233 @default.
- W3094372592 hasConceptScore W3094372592C61511704 @default.
- W3094372592 hasConceptScore W3094372592C71924100 @default.
- W3094372592 hasConceptScore W3094372592C86803240 @default.
- W3094372592 hasConceptScore W3094372592C89423630 @default.
- W3094372592 hasIssue "1" @default.
- W3094372592 hasLocation W30943725921 @default.
- W3094372592 hasLocation W30943725922 @default.
- W3094372592 hasOpenAccess W3094372592 @default.
- W3094372592 hasPrimaryLocation W30943725921 @default.
- W3094372592 hasRelatedWork W1542424619 @default.
- W3094372592 hasRelatedWork W2090609810 @default.
- W3094372592 hasRelatedWork W2346296399 @default.
- W3094372592 hasRelatedWork W2462972684 @default.
- W3094372592 hasRelatedWork W2467443547 @default.
- W3094372592 hasRelatedWork W2979138111 @default.
- W3094372592 hasRelatedWork W3110661158 @default.
- W3094372592 hasRelatedWork W31404942 @default.
- W3094372592 hasRelatedWork W37143161 @default.
- W3094372592 hasRelatedWork W2254710043 @default.
- W3094372592 hasVolume "115" @default.
- W3094372592 isParatext "false" @default.
- W3094372592 isRetracted "false" @default.
- W3094372592 magId "3094372592" @default.
- W3094372592 workType "article" @default.